InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Klichinsky Michael, Chief Scientific Officer. Insider active across 1 company, notably Carisma Therapeutics Inc.. In total, 3 reports have been recorded. Split: 0 buy · 1 sell. Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Klichinsky Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
56,982 股@ €0.0944Common StockSEC:0001104659-25-097928:0
165,000 股@ €0.21950.0% 占其流量Common StockSEC:0001104659-25-096740:0
484,347 股Common StockSEC:0001104659-23-030750:0
3 条申报中的 3 条
About Klichinsky Michael
Michael Klichinsky is the Chief Scientific Officer at Carisma Therapeutics Inc. He is responsible for overseeing the company's scientific and research initiatives, focusing on the development of new therapies. His expertise in biology and clinical research is essential for Carisma's innovation.
